Agonists for endothelial P2 purinoceptors trigger a signalling pathway producing Ca2+ responses in lymphocytes adherent to endothelial cells.

about

Agonists for endothelial P2 purinoceptors trigger a signalling pathway producing Ca2+ responses in lymphocytes adherent to endothelial cells.

Item

http://www.wikidata.org/entity/Q41901001

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Agonists for endothelial P2 pu ...... adherent to endothelial cells.

@en

type

Item

label

Agonists for endothelial P2 pu ...... adherent to endothelial cells.

@en

prefLabel

Agonists for endothelial P2 pu ...... adherent to endothelial cells.

@en

P1476

Agonists for endothelial P2 pu ...... adherent to endothelial cells.

@en

P2093

Chen JR

http://www.w3.org/2001/XMLSchema#string

Jamieson GP

http://www.w3.org/2001/XMLSchema#string

Thurlow PJ

http://www.w3.org/2001/XMLSchema#string

Wiley JS

http://www.w3.org/2001/XMLSchema#string

P2860

A new generation of Ca2+ indicators with greatly improved fluorescence properties

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1.

The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP.

Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells

Expression cloning of an ATP receptor from mouse neuroblastoma cells.

Stimulus-secretion coupling in vascular endothelial cells.

Improved sensitivity in flow cytometric intracellular ionized calcium measurement using fluo-3/Fura Red fluorescence ratios.

Overview. Purinergic mechanisms.

Further subclassification of ATP receptors based on agonist studies.

P304

589-594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BJ3110589

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

311 ( Pt 2)

http://www.w3.org/2001/XMLSchema#string

P577

1995-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15711001

http://www.w3.org/2001/XMLSchema#string

P698

7487900

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

P932

1136040

http://www.w3.org/2001/XMLSchema#string